{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:56:32Z","timestamp":1778806592909,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ygyno.2012.10.015","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T19:15:14Z","timestamp":1350933314000},"page":"364-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Migfilin, \u03b1-parvin and \u03b2-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases"],"prefix":"10.1016","volume":"128","author":[{"given":"Ben","family":"Davidson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arild","family":"Holth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai T.P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes G.","family":"Trop\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.10.015_bb0005","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0010","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ejca.2012.01.031","article-title":"Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in stage IV ovarian cancer?","volume":"48","author":"Trop\u00e9","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0020","series-title":"Serous effusions","year":"2011"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0025","first-page":"33","article-title":"Epithelial\u2013mesenchymal transition in ovarian carcinoma","volume":"2","author":"Davidson","year":"2012","journal-title":"Front Wom Cancer"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","article-title":"Role of integrins in cell invasion and migration","volume":"2","author":"Hood","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ceb.2012.06.003","article-title":"ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling","volume":"24","author":"Qin","year":"2012","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/emboj.2009.376","article-title":"The ILK\/PINCH\/parvin complex: the kinase is dead, long live the pseudokinase!","volume":"29","author":"Wickstr\u00f6m","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0045","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/onc.2011.177","article-title":"Integrin-linked kinase: not so \u2018pseudo\u2019 after all","volume":"30","author":"Hannigan","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0050","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nrc2967","article-title":"Integrin signalling adaptors: not only figurants in the cancer story","volume":"10","author":"Cabodi","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"Pt 4","key":"10.1016\/j.ygyno.2012.10.015_bb0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1242\/jcs.01639","article-title":"Migfilin and its binding partners: from cell biology to human diseases","volume":"118","author":"Wu","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0060","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/sj.onc.1206347","article-title":"Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells","volume":"22","author":"Cruet-Hennequart","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.1441","article-title":"Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid","volume":"201","author":"Ahmed","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0070","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1158\/1078-0432.CCR-03-0042","article-title":"Cell-free 59kDa immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma","volume":"10","author":"Ahmed","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0075","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1158\/0008-5472.CAN-05-2123","article-title":"Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells","volume":"65","author":"Rosan\u00f2","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0080","doi-asserted-by":"crossref","first-page":"C1532","DOI":"10.1152\/ajpcell.00478.2005","article-title":"Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium","volume":"290","author":"Ahmed","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0085","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1535-7163.MCT-05-0523","article-title":"Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma","volume":"5","author":"Rosan\u00f2","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0090","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yexcr.2006.11.003","article-title":"Critical involvement of ILK in TGFbeta1-stimulated invasion\/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system","volume":"313","author":"Lin","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jcp.21774","article-title":"Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription","volume":"220","author":"L\u00f6ssner","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0100","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1158\/1078-0432.CCR-06-1059","article-title":"Gene expression signatures differentiate ovarian\/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma","volume":"12","author":"Davidson","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2303.2010.00757.x","article-title":"PINCH-2 expression in cancers involving the serosal cavities using quantitative PCR","volume":"22","author":"Yuan","year":"2011","journal-title":"Cytopathology"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0115","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.ejca.2008.07.021","article-title":"Expression of integrin-linked kinase and its binding partners in chondrosarcoma: association with prognostic significance","volume":"44","author":"Papachristou","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0092-8674(03)00163-6","article-title":"Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation","volume":"113","author":"Tu","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0125","doi-asserted-by":"crossref","first-page":"41695","DOI":"10.1074\/jbc.M401563200","article-title":"Distinct roles of two structurally closely related focal adhesion proteins, alpha-parvins and beta-parvins, in regulation of cell morphology and survival","volume":"279","author":"Zhang","year":"2004","journal-title":"J Biol Chem"},{"issue":"Pt 24","key":"10.1016\/j.ygyno.2012.10.015_bb0130","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1242\/jcs.112.24.4589","article-title":"Integrin-linked kinase is localized to cell\u2013matrix focal adhesions but not cell\u2013cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats","volume":"112","author":"Li","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0135","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1994.12.9.1748","article-title":"Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study","volume":"12","author":"Thigpen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0145","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/cncr.26449","article-title":"Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome","volume":"118","author":"Kim","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humpath.2007.10.002","article-title":"Claudin upregulation in ovarian carcinoma effusions is associated with poor survival","volume":"39","author":"Kleinberg","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.22426","article-title":"Nuclear expression of Survivin is associated with improved survival in metastatic ovarian carcinoma","volume":"109","author":"Kleinberg","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0160","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.humpath.2009.09.017","article-title":"Mammalian target of rapamycin is a biomarker of poor survival in metastatic ovarian carcinoma","volume":"41","author":"Bunkholt Elstrand","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.humpath.2008.10.019","article-title":"Cleaved caspases and NF-\u03baB p65 are prognostic factors in metastatic ovarian carcinoma","volume":"40","author":"Kleinberg","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","article-title":"\u03b21-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro","volume":"73","author":"Strobel","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0175","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0002-9440(10)65406-5","article-title":"CD44 and \u03b21 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells","volume":"154","author":"Lessan","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0180","first-page":"11","article-title":"Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models","volume":"15","author":"Kishikawa","year":"1995","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0090-8258(03)00321-4","article-title":"AlphaV and \u03b21 integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients","volume":"90","author":"Davidson","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1027340208536","article-title":"Expression of the 67kDa laminin receptor and the \u03b16 integrin subunit in serous ovarian carcinoma","volume":"20","author":"Givant-Horwitz","year":"2003","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M","article-title":"E-cadherin and \u03b1-, \u03b2- and \u03b3-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions","volume":"192","author":"Davidson","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0205","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00428-006-0274-6","article-title":"Expression of E-cadherin transcriptional regulators in ovarian carcinoma","volume":"449","author":"Elloul","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/MCB.01617-06","article-title":"Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation","volume":"28","author":"Johnstone","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0215","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.bjc.6605835","article-title":"Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract","volume":"103","author":"Wu","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0220","doi-asserted-by":"crossref","first-page":"34308","DOI":"10.1074\/jbc.M109.045021","article-title":"Migfilin interacts with Src and contributes to cell\u2013matrix adhesion-mediated survival signaling","volume":"284","author":"Zhao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2559.2007.02791.x","article-title":"Increased cytoplasmic level of migfilin is associated with higher grades of human leiomyosarcoma","volume":"51","author":"Papachristou","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0230","doi-asserted-by":"crossref","first-page":"32394","DOI":"10.1074\/jbc.M112.393900","article-title":"Migfilin protein promotes migration and invasion in human glioma through epidermal growth factor receptor-mediated phospholipase C-\u00e3 and STAT3 protein signaling pathways","volume":"287","author":"Ou","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2012.10.015_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1541-7786.MCR-11-0419","article-title":"Migfilin regulates esophageal cancer cell motility through promoting GSK-3\u03b2-mediated degradation of \u03b2-catenin","volume":"10","author":"He","year":"2012","journal-title":"Mol Cancer Res"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:33:39Z","timestamp":1758771219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812008414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0090825812008414"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.10.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Migfilin, \u03b1-parvin and \u03b2-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}